BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹75 Cr | ₹71 Cr | ₹15 Cr | ₹68 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of BLISS GVS PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹75 Cr |
Mar2023 | ₹71 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹68 Cr |
Mar2020 | ₹97 Cr |
How is Consolidated Net Profit of BLISS GVS PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹75 Cr | 6.48 | |
Mar2023 | ₹71 Cr | 371.14 | |
Mar2022 | ₹15 Cr | -78.04 | |
Mar2021 | ₹68 Cr | -29.58 | |
Mar2020 | ₹97 Cr | - |
Compare Consolidated Net Profit of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,241.6 Cr | -3.5% | -1.3% | -2.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 2.3% | 5.6% | 21.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | 1.5% | 4.2% | 51.2% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | 0% | 2.9% | 10% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | 0.6% | 0.9% | 23.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | 0.8% | 1.8% | -5.4% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -3.5% |
-1.3% |
-2.9% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses